Discuss the strategic shift from mass vaccination to surveillance-containment that enabled smallpox eradication in India. What lessons does it offer for present-day disease elimination programmes (e.g., TB, malaria)?

Smallpox is the only human disease ever eradicated, certified in December 1979 and declared free at the 33rd World Health Assembly in May 1980 [2]. India's decisive gain came less from vaccinating more people than from vaccinating the right people — a pivot from blanket coverage to active case-finding.

Why mass vaccination plateaued

• Decades of mass vaccination raised coverage statistics, yet transmission persisted in dense, highly mobile populations, with large outbreaks still reported in the early 1970s [3].
• The programme's metric was doses delivered, not chains of transmission broken; outbreaks were detected only after they had spread.

The surveillance-containment strategy

• Search and containment (pioneered in the SEP from 1967) inverted the logic: locate every case, then ring-vaccinate contacts and the surrounding village [1].
• India's intensified campaign (1973–75) used house-to-house searches, rewards for reporting cases, and mobile containment teams of young medical interns under Centre–State review machinery [3].
• Two enabling technologies made this feasible in tropical field conditions — the freeze-dried thermo-stable vaccine (potent for 30 days in a health worker's bag) and the bifurcated needle, which used one-fourth the vaccine dose [1].
• Outcome: India's last indigenous case on 17 May 1975 in Bihar, smallpox eliminated from Asia in 1975, and nationwide searches of over 110 million households in 1976 confirming zero cases [1][3].
• Sustained political ownership mattered; the Union Health Minister in 1976 cautioned against eradication being crowded out by the family planning drive [6].

Lessons for TB and malaria

• Shift the metric from coverage to detection: the TB Mukt Bharat Abhiyan's screening drive found lakhs of asymptomatic patients missed by passive reporting [4].
• Last-mile, district-level micro-targeting, as under the National Framework for Malaria Elimination's zero-indigenous-case goal for 2027 [5].
• Cheap, field-robust tools plus community incentives outperform expensive centralised campaigns — eradication cost about US$300 million but saves over US$1 billion yearly [2].

Smallpox proves elimination is an administrative and epidemiological problem as much as a medical one. Embedding surveillance-led targeting, local accountability and frugal innovation into TB and malaria programmes can convert India's declining caseloads into genuine elimination, advancing SDG-3's promise of health for all.